Integra LifeSciences Holdings Co (NASDAQ: IART) has reported E.P.S. of $0.25 for its fourth fiscal quarter (ending December 31) versus $0.26 for the same period a year ago — a decline of -4%. For the latest four quarters through December 31, E.P.S. were $-0.09 compared to $0.85 a year ago — a decline of -111%.
Recent Price Action
On 2/25/25, Integra LifeSciences Holdings Co (NASDAQ: IART) stock enjoyed a major increase of 12.1%, closing at $24.72. Moreover, trading volume in this advance was exceptionally high at 328% of normal. Relative to the market the stock has been weak over the last nine months but has risen 2.2% during the last week.
Current PriceTarget Research Rating
Integra LifeSciences Holdings has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Integra LifeSciences Holdings has a good Appreciation Score of 79 but a slightly negative Power Rating of 33, with the Neutral Value Trend Rating the result.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment